ACCEPTED MANUSCRIPT
[
23]G.A. Holdgate, A. Tunnicliffe, W.H.J. Ward, S.A. Weston, G. Rosenbrock, P.T. Barth, I.W.F. Taylor,
R.A. Pauptit, D. Timms, The entropic penalty of ordered water accounts for weaker binding of the
antibiotic novobiocin to a resistant mutant of DNA gyrase: a thermodynamic and crystallographic
study. Biochemistry 36 (1997) 9663
24]V. Škedelj, T. Tomašić, L. Peterlin Mašič, A. Zega, ATP-binding site of bacterial enzymes as a target
for antibacterial drug design, J. Med. Chem. 54 (2011) 915 929.
–9673.
[
[
–
25]M. Oblak, S.G. Grdadolnik, M. Kotnik, R. Jerala, M. Filipič, T. Solmajer, In silico fragment-based
discovery of indolin-2-one analogues as potent DNA gyrase inhibitors, Bioorg. Med. Chem. Lett. 15
(
2005) 5207
26]M. Brvar, A. Perdih, M. Renko, G. Anderluh, D. Turk, T. Solmajer, Structure based discovery of
substituted 4,5'-bithiazoles as novel DNA gyrase inhibitors, J. Med. Chem. 55 (2012) 6413 6426.
–5210.
[
[
–
27]P.S. Charifson, A.L. Grillot, T.H. Grossman, J.D. Parsons, M. Badia, S. Bellon, D.D. Deininger, J.E.
Drumm, C.H. Gross, A. LeTiran, Y.S. Liao, N. Mani, D.P. Nicolau, E. Perola, S. Ronkin, D. Shannon,
L.L. Swenson, Q. Tang, P.R. Tessier, S.K. Tian, M. Trudeau, T.S. Wang, Y.Y. Wei, H. Zhang, D.
Stamos, Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV
possessing potent antibacterial activity: intelligent design and evolution through the judicious use of
structure guided design and stucture-activity relationships, J. Med. Chem. 51 (2008) 5243–5263.
[
[
[
[
28]J. Zhang, Q. Yang, J.B. Cross, J.A.C. Romero, K.M. Poutsiaka, F. Epie, D. Bevan, B. Wang, Y. Zhang,
A. Chavan, X. Zhang, T. Moy, A. Daniel, K. Nguyen, B. Chamberlain, N. Carter, J. Shotwell, J.
Silverman, C.A. Metcalf, D. Ryan, B. Lippa, R.E. Dolle, Discovery of Azaindole Ureas as a Novel
Class of Bacterial Gyrase B Inhibitors, J. Med. Chem. 58 (2015) 8503–8512.
29]J. Zhang, Q. Yang, J.A.C. Romero, J. Cross, B. Wang, K.M. Poutsiaka, F. Epie, D. Bevan, Y. Wu, T.
Moy, A. Daniel, B. Chamberlain, N. Carter, J. Shotwell, A. Arya, V. Kumar, J. Silverman, K. Nguyen,
C.A. Metcalf, D. Ryan, B. Lippa, R.E. Dolle, Discovery of Indazole Derivatives as a Novel Class of
Bacterial Gyrase B Inhibitors, Med. Chem. Lett. 6 (2015) 1080–1085.
30]V.U. Jeankumar, J. Renukaa, V.K. Pulla, V. Soni, J.P. Sridevi, P. Suryadevara, M. Shravana, R.
Medishetti, P. Kulkarni, P. Yogeeswari, D. Sriram, Development of novel N-linked aminopiperidine-
based mycobacterial DNA gyrase B inhibitors: Scaffold hopping from known antibacterial leads, Int. J.
Antimicrob. Ag. 43 (2014) 269–278.
31]B.A. Sherer, K. Hull, O. Green, G. Basarab, S. Hauck, P. Hill, J.T. Loch, G. Mullen, S. Bist, J. Bryant,
A. Boriack-Sjodin, J. Read, N. DeGrace, M. Uria-Nickelsen, R.N. Illingworth, A.E. Eakin,
Pyrrolamide DNA gyrase inhibitors: optimization of antibacterial activity and efficacy, Bioorg. Med.
Chem. Lett. 21 (2011) 7416–7420.
[
32]R.J. Lewis, O.M. Singh, C.V. Smith, T. Skarzynski, A. Maxwell, A.J. Wonacott, D.B. Wigley, The
nature of inhibition of DNA gyrase by the coumarins and the cyclothialidines revealed by X-ray
crystallography, EMBO J. 15 (1996) 1412–1420.
[
[
33]J.J. Champoux, DNA topoisomerases: Structure, function, and mechanism, Annu. Rev. Biochem. 70
(
2001) 369−413.
34]L.W. Tari, X. Li, M. Trzoss, D.C. Bensen, Z. Chen, T. Lam, J. Zhang, S.J. Lee, G. Hough, D.
Phillipson, S. Akers-Rodriguez, M.L. Cunningham, B.P. Kwan, K.J. Nelson, A. Castellano, J.B. Locke,
V. Brown-Driver, T.M. Murphy, V.S. Ong, C.M. Pillar, D.L. Shinabarger, J. Nix, F.C. Lightstone, S.E.
Wong, T.B. Nguyen, K.J. Shaw, J. Finn, Tricyclic GyrB/ParE (TriBE) inhibitors: a new class of broad-
spectrum dual-targeting antibacterial agents, PLoS One 8 (2013) 1–13.
[
[
35]L.W. Tari, M. Trzoss, D.C. Bensen, X. Li, Z. Chen, T. Lam, J. Zhang, C.J. Creighton, M.L.
Cunningham, B. Kwan, M. Stidham, K.J. Shaw, F.C. Lightstone, S.E. Wong, T.B. Nguyen, J. Nix, J.
Finn, Pyrrolopyrimidine inhibitors of DNA gyrase B (GyrB) and topoisomerase IV (ParE). Part I:
Structure guided discovery and optimization of dual targeting agents with potent, broad-spectrum
enzymatic activity, Bioorg. Med. Chem. Lett. 23 (2013) 1529–1536.
36]M. Trzoss, D.C. Bensen, X.M. Li, Z.Y. Chen, T. Lam, J.H. Zhang, C.J. Creighton, M.L. Cunningham,
B. Kwan, , M. Stidham, K. Nelson, V. Brown-Driver, A. Castellano, K.J. Shaw, F.C. Lightstone, S.E.
Wong, T.B. Nguyen, J. Finn, L.W. Tari, Pyrrolopyrimidine inhibitors of DNA gyrase B (GyrB) and
topoisomerase IV (ParE), Part II: development of inhibitors with broad spectrum Gram-negative
antibacterial activity, Bioorg Med. Chem. Lett. 23 (2013) 1537–1543.